ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD): CURRENT APPROACHES TO DIAGNOSIS AND TREATMENT
International Journal of Drug Delivery Technology · 20.06.2026 · 16 (57s)
DOI: 10.25258/ijddt.16.57s.30 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 20.06.2026. Verfasst von Samridhi Chawla und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Attention Deficit Hyperactivity Disorder (ADHD) is one of the most prevalent neurodevelopmental disorders affecting children and adolescents worldwide, with symptoms frequently persisting into adulthood. Characterized by persistent patterns of inattention, hyperactivity, and impulsivity, ADHD significantly impacts academic performance, social interactions, emotional well-being, and overall quality of life. The etiology of ADHD is multifactorial, involving complex interactions among genetic, neurobiological, environmental, and psychosocial factors. Early recognition and accurate diagnosis are essential for minimizing functional impairment and improving long-term outcomes. Current diagnostic approaches rely on comprehensive clinical assessment using standardized diagnostic criteria, detailed developmental history, behavioral observations, and validated rating scales obtained from multiple informants, including parents, teachers, and caregivers. Advances in neuroimaging, genetic research, and digital health technologies have enhanced understanding of the disorder, although no definitive biological marker is currently available for routine clinical diagnosis. Management of ADHD requires a multimodal and individualized approach. Evidence-based behavioral interventions, parent training programs, classroom modifications, psychoeducation, and cognitive-behavioral strategies form the cornerstone of non-pharmacological treatment. Pharmacotherapy remains highly effective, particularly stimulant medications such as methylphenidate and amphetamine derivatives, while non-stimulant agents including atomoxetine, guanfacine, and clonidine provide valuable alternatives in selected patients. Emerging therapeutic modalities, including digital therapeutics, neurofeedback, telemedicine-based care, and precision medicine approaches, offer promising opportunities for personalized treatment and improved accessibility. Continuous monitoring, family involvement, and multidisciplinary collaboration are critical for optimizing treatment adherence and functional outcomes. This narrative review summarizes current concepts regarding the epidemiology, pathophysiology, diagnosis, and management of ADHD, with particular emphasis on contemporary diagnostic strategies, evidence-based therapeutic interventions, recent advances, and future directions in clinical practice.
Zitieren
APA
Chawla, S., Antil, R., & Singh, A. (2026). ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD): CURRENT APPROACHES TO DIAGNOSIS AND TREATMENT. International Journal of Drug Delivery Technology, 16(57s). https://doi.org/10.25258/ijddt.16.57s.30
Vancouver
Chawla S, Antil R, Singh A. ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD): CURRENT APPROACHES TO DIAGNOSIS AND TREATMENT. International Journal of Drug Delivery Technology. 2026;16(57s). doi:10.25258/ijddt.16.57s.30
BibTeX
@article{Chawla2026,
author = {Chawla, Samridhi and Antil, Rashmi and Singh, Ashima},
title = {ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD): CURRENT APPROACHES TO DIAGNOSIS AND TREATMENT},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {57s},
doi = {10.25258/ijddt.16.57s.30}
}
EUVIMED